Stability of Ceftizoxime in 5 Percent Dextrose and 0.9 Percent Sodium Chloride
DOI:
https://doi.org/10.4212/cjhp.v46i1.2461Keywords:
ceftizoxime, stability, IV admixture, mélange de solutions intraveineuses, stabilitéAbstract
ABSTRACT
The chemical stability of ceftizoxime, 1g/50mL minibag, was examined under room temperature, refrigerated and frozen conditions. Solutions of ceftizoxime were prepared in 0.9% NaCL (NS) and 5% Dextrose (D5W) and concentrations were determined for up to 90 days by high performance liquid chromatography. Ceftizoxime solutions (in either NS or D5W) of 1g/50mL minibag retained greater than 90% of their original concentration for 30 days when stored in the refrigerator. When solutions were stored at room temperature, more than 90% of the initial concentration remained for up to 4 days. When frozen, these solutions retained greater than 90% of their original concentration for up to 90 days. Subsequent thawed solutions retained chemical stability for 30 days when kept in the refrigerator.
RÉSUMÉ
On a évalué la stabilité chimique des solutions de ceftizoxime (1 g/50 mL en mini-sac) à la température ambiante, au réfrigérateur et au congélateur. Pour cela, on a déterminé la concentration de solutions de ceftizoxime dans du NaCl à 0,9 % (NS) et du dextrose à 5 % (D5W) par chromatographie en phase liquide à haute résolution pendant une période allant jusqu'à 90 jours. Entreposés au réfrigérateur, les solutions de ceftizoxime (1 g/50 mL en mini-sac, dans le NS ou le D5W) retiennent plus de 90 % de leur concentration initiale pendant 30 jours. À température ambiante, ces solutions conservent 90 % de leur concentration initiale jusqu'à 4 jours. Congelées, elles retiennent plus de 90 % de leur concentration initiale jusqu'à 90 jours. Après décongélation, elles peuvent conserver leur stabilité chimique pour 30 jours lorsqu'on les place au réfrigérateur.
Downloads
Downloads
Published
Issue
Section
License
Copyright © Canadian Society of Healthcare-Systems Pharmacy.
After publication of a manuscript in the CJHP, the authors of the manuscript must obtain written permission from the CSHP (publications@cshp.ca) before reproducing any text, figures, tables, or illustrations from the work in future works of their own. If a submitted manuscript is declined for publication in the CJHP, all said rights shall revert to the authors. Please note that any forms (e.g., preprinted orders and patient intake forms) used by a specific hospital or other health care facility and included as illustrative material with a manuscript are exempt from this copyright transfer. The CJHP will require a letter from the hospital or health care facility granting permission to publish the document(s).